Important information regarding journalistic and media representation of UT Southwestern.

– In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center, a short interfering RNA (siRNA) drug directed to tumor cells, ARO-HIF2, effectively disrupted HIF2α, a key driver of clear cell renal cell carcinoma (ccRCC).

Email Address (you@someplace.com) *Required × Error: A field is missing data or special characters were used. Please correct. Recipient Email Address (recipient@someplace.com) *Required × Error: A field is missing data or special characters were used. Please correct. × Error: A field is missing data or special characters were used. Please correct. Optional Message × Error: A field is missing data or special characters were used. Please correct. Yes! Send me news from UT Southwestern Medical

UTSW research finds significant disparities exist in diagnosing and treating headaches by race, socioeconomic level, and insurance status.

UT Southwestern Medical Center is the first facility in Dallas and the surrounding region to participate in the international COLCORONA trial.

With new findings that show an unprecedented jump in nicotine-containing electronic cigarette usage among teens, many parents wonder how best to approach the topic.

We are making significant progress on uncovering the roots of Alzheimer’s.

Researchers and collaborators made a key discovery regarding cellular processes that block pathways in immune cells that lead to sepsis.

A study that identifies how a coronavirus protein called Nsp1 blocks the activity of genes that promote viral replication provides hope for new COVID-19 treatments.

Ushering in a new era in cancer care in Fort Worth, UT Southwestern Medical Center broke ground today on a $177 million Radiation Oncology campus that will provide the most advanced therapies for patients of the nation’s 12th largest city.